title: Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.
abstract: From January through June of 1998, 4579 bloodstream infections (BSI) due to bacterial pathogens were reported from SENTRY hospitals in Canada, the USA and Latin America. Staphylococcus aureus, Escherichia coli, and coagulase-negative staphylococcus (CoNS) were the most common pathogens, together accounting for 55.2% of all BSI during this time period. Compared with the 5794 BSI reported from SENTRY from January through June of 1997, no major change was seen in the frequencies of occurrence of the most common bacterial causes of BSI. Between 1997 and 1998, the major change in antimicrobial resistance was an increase in oxacillin-resistance in both S. aureus and CoNS in all regions. These data demonstrate widespread antimicrobial resistance in Canada, Latin America and the USA, with a notable increase in oxacillin-resistance among staphylococci. Ongoing surveillance remains essential, and will enhance efforts to limit the scope of this worldwide problem.
authors.affiliation: Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA. daniel-diekema@uiowa.edu
authors.forename: D J
authors.initials: DJ
authors.lastname: Diekema
authors.forename: M A
authors.initials: MA
authors.lastname: Pfaller
authors.forename: R N
authors.initials: RN
authors.lastname: Jones
authors.forename: G V
authors.initials: GV
authors.lastname: Doern
authors.forename: K C
authors.initials: KC
authors.lastname: Kugler
authors.forename: M L
authors.initials: ML
authors.lastname: Beach
authors.forename: H S
authors.initials: HS
authors.lastname: Sader
mesh_terms: D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D015373:Bacterial Typing Techniques; D002170:Canada / Q000453:epidemiology; D004269:DNA, Bacterial / Q000032:analysis; D004275:DNA, Ribosomal / Q000032:analysis; D004352:Drug Resistance, Microbial; D006090:Gram-Negative Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D006094:Gram-Positive Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D006801:Humans; D007843:Latin America / Q000453:epidemiology; D008826:Microbial Sensitivity Tests; D014481:United States / Q000453:epidemiology
chemical_list: D004269:DNA, Bacterial; D004275:DNA, Ribosomal